Glück Conviction Score™ ⓘ
Score-Verlauf (90 Tage)
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 4.85 | +15.7 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 5.16 | +8.7 % vs SMA200 | |
| SMA-Cross | Bärisch | 10 % | DEATH | vor 38 Tagen @ 3.99 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 5.73 | EMA50: 5.32 | |
| MACD-Histogramm | Bärisch | 10 % | -0.142 | Bearisch | |
| RSI(14) | Neutral | 10 % | 50.0 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 24.8 | Neutral | |
| ADX(14)+DI | Bullisch | 10 % | 33.4 | +DI: 17.4 / −DI: 16.3 | |
| Z-Score(60) | Neutral | 5 % | 0.82 | In Range | |
| 52W-Position | Neutral | 5 % | 52.8 % | Hoch 8.48 / Tief 2.40 | |
| Bollinger(20,2σ) | Neutral | 5 % | 22.5 % | Upper 6.76 / Mid 6.02 / Lower 5.27 | |
| LinReg-Slope(60) | Bullisch | 10 % | +0.0566 | R²=0.71 / annualisiert +305.9 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-27 | BROADWOOD PARTNERS, L.P. | 10% Owner | Open Market Purchase | 250.923 | 3,64 | 913.133,89 | +224,9% | |
| 2026-04-27 | BROADWOOD PARTNERS, L.P. | 10% Owner | Open Market Purchase | 0 | 0,00 | 0,00 | 0,0% | |
| 2026-04-24 | BROADWOOD PARTNERS, L.P. | 10% Owner | Open Market Purchase | 38.880 | 3,53 | 137.083,10 | +33,8% | |
| 2026-04-24 | BROADWOOD PARTNERS, L.P. | 10% Owner | Open Market Purchase | 0 | 0,00 | 0,00 | 0,0% | |
| 2026-04-23 | BROADWOOD PARTNERS, L.P. | 10% Owner | Open Market Purchase | 0 | 0,00 | 0,00 | 0,0% | |
| 2026-04-23 | BROADWOOD PARTNERS, L.P. | 10% Owner | Open Market Purchase | 280.381 | 3,50 | 982.034,45 | +241,8% | |
| 2026-04-20 | BROADWOOD PARTNERS, L.P. | 10% Owner | Open Market Purchase | 40.690 | 3,88 | 157.966,72 | +38,9% | |
| 2026-04-20 | BROADWOOD PARTNERS, L.P. | 10% Owner | Open Market Purchase | 0 | 0,00 | 0,00 | 0,0% | |
| 2026-04-17 | BROADWOOD PARTNERS, L.P. | 10% Owner | Open Market Purchase | 40.114 | 3,57 | 143.251,11 | +35,3% | |
| 2026-04-17 | BROADWOOD PARTNERS, L.P. | 10% Owner | Open Market Purchase | 0 | 0,00 | 0,00 | 0,0% | |
| 2026-04-16 | BROADWOOD PARTNERS, L.P. | 10% Owner | Open Market Purchase | 102.057 | 3,45 | 351.657,80 | +86,6% | |
| 2026-04-16 | BROADWOOD PARTNERS, L.P. | 10% Owner | Open Market Purchase | 0 | 0,00 | 0,00 | 0,0% | |
| 2026-02-10 | BROADWOOD PARTNERS, L.P. | 10% Owner | Open Market Purchase | 0 | 0,00 | 0,00 | 0,0% | |
| 2026-02-10 | BROADWOOD PARTNERS, L.P. | 10% Owner | Open Market Purchase | 521.739 | 5,75 | 2.999.999,25 | +738,8% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC | 11.931.839 | 11.410.100 | 521.739 | 39.136.432 | Aufgestockt | +4,6% | |
| AWM Investment Company, Inc. | 2.806.256 | 2.814.230 | -7.974 | 9.204.520 | Reduziert | -0,3% | |
| VANGUARD GROUP INC | 526.675 | 0 | 526.675 | 3.950.064 | Neu | +100,0% | |
| PURA VIDA INVESTMENTS, LLC | 947.134 | 947.134 | 0 | 3.106.600 | Unverändert | 0,0% | |
| Alyeska Investment Group, L.P. | 840.777 | 0 | 840.777 | 2.757.749 | Neu | +100,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 537.161 | 0 | 537.161 | 1.761.888 | Neu | +100,0% | |
| HEIGHTS CAPITAL MANAGEMENT, INC | 392.545 | 0 | 392.545 | 1.287.548 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 262.053 | 230.971 | 31.082 | 860.170 | Aufgestockt | +13,5% | |
| BlackRock, Inc. | 135.345 | 131.361 | 3.984 | 443.932 | Aufgestockt | +3,0% | |
| Family Office Research LLC | 127.266 | 0 | 127.266 | 417.432 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 103.470 | 61.377 | 42.093 | 339.382 | Aufgestockt | +68,6% | |
| JANE STREET GROUP, LLC | 42.469 | 0 | 42.469 | 318.517 | Neu | +100,0% | |
| Ghisallo Capital Management LLC | 70.695 | 0 | 70.695 | 231.880 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 56.093 | 72.451 | -16.358 | 183.985 | Reduziert | -22,6% | |
| GOLDMAN SACHS GROUP INC | 23.965 | 0 | 23.965 | 179.738 | Neu | +100,0% | |
| STATE STREET CORP | 50.754 | 47.754 | 3.000 | 166.473 | Aufgestockt | +6,3% | |
| NORTHERN TRUST CORP | 49.090 | 48.858 | 232 | 161.015 | Aufgestockt | +0,5% | |
| MORGAN STANLEY | 36.088 | 35.913 | 175 | 118.369 | Aufgestockt | +0,5% | |
| CITADEL ADVISORS LLC | 15.647 | 0 | 15.647 | 117.353 | Neu | +100,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 13.400 | 0 | 13.400 | 100.500 | Neu | +100,0% | |
| XTX Topco Ltd | 30.353 | 0 | 30.353 | 99.558 | Neu | +100,0% | |
| Hudson Bay Capital Management LP | 13.061 | 0 | 13.061 | 97.958 | Neu | +100,0% | |
| 683 Capital Management, LLC | 29.000 | 77.204 | -48.204 | 95.120 | Reduziert | -62,4% | |
| Qube Research & Technologies Ltd | 25.230 | 28.351 | -3.121 | 82.754 | Reduziert | -11,0% | |
| OSAIC HOLDINGS, INC. | 24.135 | 24.136 | -1 | 79.162 | Reduziert | 0,0% | |
| UBS Group AG | 22.751 | 2.941 | 19.810 | 74.624 | Aufgestockt | +673,6% | |
| Engineers Gate Manager LP | 18.253 | 0 | 18.253 | 59.870 | Neu | +100,0% | |
| Flatrock Wealth Partners LLC | 13.044 | 13.044 | 0 | 42.785 | Unverändert | 0,0% | |
| Point72 Asset Management, L.P. | 12.250 | 0 | 12.250 | 40.180 | Neu | +100,0% | |
| OMERS ADMINISTRATION Corp | 10.500 | 26.164 | -15.664 | 34.440 | Reduziert | -59,9% | |
| Private Advisor Group, LLC | 10.416 | 10.416 | 0 | 34.164 | Unverändert | 0,0% | |
| EverSource Wealth Advisors, LLC | 5.000 | 5.000 | 0 | 16.400 | Unverändert | 0,0% | |
| Advisory Services Network, LLC | 3.100 | 0 | 3.100 | 10.168 | Neu | +100,0% | |
| ORG Partners LLC | 450 | 0 | 450 | 3.375 | Neu | +100,0% | |
| CITIGROUP INC | 815 | 1 | 814 | 2.673 | Aufgestockt | +81400,0% | |
| BANK OF AMERICA CORP /DE/ | 335 | 0 | 335 | 2.513 | Neu | +100,0% | |
| Tower Research Capital LLC (TRC) | 250 | 0 | 250 | 1.875 | Neu | +100,0% | |
| Ascentis Independent Advisors | 450 | 0 | 450 | 1.476 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 154 | 0 | 154 | 1.155 | Neu | +100,0% | |
| FNY Investment Advisers, LLC | 247.421 | 40.584 | 206.837 | 811 | Aufgestockt | +509,7% | |
| SBI Securities Co., Ltd. | 185 | 185 | 0 | 607 | Unverändert | 0,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 64 | 30 | 34 | 210 | Aufgestockt | +113,3% | |
| Piscataqua Savings Bank | 25 | 25 | 0 | 81 | Unverändert | 0,0% | |
| Cassaday & Co Wealth Management LLC | 10 | 0 | 10 | 33 | Neu | +100,0% | |
| ALBION FINANCIAL GROUP /UT | 7 | 7 | 0 | 23 | Unverändert | 0,0% | |
| Global Retirement Partners, LLC | 1 | 0 | 1 | 8 | Neu | +100,0% | |
| Federation des caisses Desjardins du Quebec | 1 | 0 | 1 | 3 | Neu | +100,0% | |
| Caitong International Asset Management Co., Ltd | 1 | 0 | 1 | 3 | Neu | +100,0% | |
| Farther Finance Advisors, LLC | 1 | 0 | 1 | 3 | Neu | +100,0% | |
| Motiv8 Investments LLC | 10 | 0 | 10 | 0 | Neu | +100,0% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC | 11.931.839 | 11.410.100 | +4,6% | 39.136.432 | 64,31 |
| AWM Investment Company, Inc. | 2.806.256 | 2.814.230 | -0,3% | 9.204.520 | 15,13 |
| PURA VIDA INVESTMENTS, LLC | 947.134 | 947.134 | 0,0% | 3.106.600 | 5,11 |
| Alyeska Investment Group, L.P. | 840.777 | 0 | +100,0% | 2.757.749 | 4,53 |
| VANGUARD CAPITAL MANAGEMENT LLC | 537.161 | 0 | +100,0% | 1.761.888 | 2,90 |
| HEIGHTS CAPITAL MANAGEMENT, INC | 392.545 | 0 | +100,0% | 1.287.548 | 2,12 |
| GEODE CAPITAL MANAGEMENT, LLC | 262.053 | 230.971 | +13,5% | 860.170 | 1,41 |
| BlackRock, Inc. | 135.345 | 131.361 | +3,0% | 443.932 | 0,73 |
| Family Office Research LLC | 127.266 | 0 | +100,0% | 417.432 | 0,69 |
| MILLENNIUM MANAGEMENT LLC | 103.470 | 61.377 | +68,6% | 339.382 | 0,56 |
| Ghisallo Capital Management LLC | 70.695 | 0 | +100,0% | 231.880 | 0,38 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 56.093 | 72.451 | -22,6% | 183.985 | 0,30 |
| STATE STREET CORP | 50.754 | 47.754 | +6,3% | 166.473 | 0,27 |
| NORTHERN TRUST CORP | 49.090 | 48.858 | +0,5% | 161.015 | 0,26 |
| MORGAN STANLEY | 36.088 | 35.913 | +0,5% | 118.369 | 0,19 |
| XTX Topco Ltd | 30.353 | 0 | +100,0% | 99.558 | 0,16 |
| 683 Capital Management, LLC | 29.000 | 77.204 | -62,4% | 95.120 | 0,16 |
| Qube Research & Technologies Ltd | 25.230 | 28.351 | -11,0% | 82.754 | 0,14 |
| OSAIC HOLDINGS, INC. | 24.135 | 24.136 | 0,0% | 79.162 | 0,13 |
| UBS Group AG | 22.751 | 2.941 | +673,6% | 74.624 | 0,12 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 41 | 19,5 | 63 |
| 31.12.2025 | ✓ | 36 | 16,7 | 125 |
| 30.09.2025 | ✓ | 27 | 16,3 | 54 |
| 30.06.2025 | ✓ | 30 | 15,3 | 49 |
| 31.03.2025 | ✓ | 29 | 16,0 | 49 |
| 31.12.2024 | ✓ | 26 | 8,4 | 20 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| 683 Capital Management, LLC | 77.204 | 579.030 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 72.451 | 543.383 |
| JANE STREET GROUP, LLC | 42.469 | 318.517 |
| Qube Research & Technologies Ltd | 28.351 | 212.633 |
| OMERS ADMINISTRATION Corp | 26.164 | 196.230 |
| GOLDMAN SACHS GROUP INC | 23.965 | 179.738 |
| Hudson Bay Capital Management LP | 13.061 | 97.958 |
| Flatrock Wealth Partners LLC | 13.044 | 42.785 |
| CITIGROUP INC | 1 | 8 |
| Motiv8 Investments LLC | 10 | 0 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| BlackRock, Inc. | 131.361 | 43.410 | +49.4 % | 985.208 |
| VANGUARD GROUP INC | 526.675 | 39.937 | +8.2 % | 3.950.064 |
| GEODE CAPITAL MANAGEMENT, LLC | 230.971 | 32.518 | +16.4 % | 1.733.670 |
| NORTHERN TRUST CORP | 48.858 | 15.968 | +48.5 % | 366.435 |
| OSAIC HOLDINGS, INC. | 24.136 | 12.920 | +115.2 % | 181.019 |
| STATE STREET CORP | 47.754 | 5.900 | +14.1 % | 358.155 |
| CITADEL ADVISORS LLC | 15.647 | 3.860 | +32.7 % | 117.353 |
| UBS Group AG | 2.941 | 227 | +8.4 % | 22.058 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| MORGAN STANLEY | 35.913 | -26.295 | -42.3 % | 269.348 |
| FNY Investment Advisers, LLC | 40.584 | -12.493 | -23.5 % | 304 |
| MILLENNIUM MANAGEMENT LLC | 61.377 | -11.914 | -16.3 % | 460.328 |
| RENAISSANCE TECHNOLOGIES LLC | 13.400 | -10.200 | -43.2 % | 100.500 |
| AWM Investment Company, Inc. | 2.814.230 | -8.300 | -0.3 % | 21.106.725 |
| Tower Research Capital LLC (TRC) | 250 | -374 | -59.9 % | 1.875 |
| BANK OF AMERICA CORP /DE/ | 335 | -111 | -24.9 % | 2.513 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 28.04.2026 | Neal C. Bradsher | Aktivist (13D/A) | 39,70 % | 12.835.134 | +2,30 pp | The Reporting Persons are filing this Schedule 13D/A to report a change in their respect… |
| 28.04.2026 | Broadwood Partners, L.P. | Aktivist (13D/A) | 39,70 % | 12.834.977 | +2,30 pp | The Reporting Persons are filing this Schedule 13D/A to report a change in their respect… |
| 28.04.2026 | Broadwood Capital, Inc. | Aktivist (13D/A) | 39,70 % | 12.834.977 | +2,30 pp | The Reporting Persons are filing this Schedule 13D/A to report a change in their respect… |
| 12.02.2026 | Broadwood Capital, Inc. | Aktivist (13D/A) | 37,40 % | 12.081.932 | -0,20 pp | The Reporting Persons acquired their Shares for investment and are filing this Schedule … |
| 12.02.2026 | Broadwood Partners, L.P. | Aktivist (13D/A) | 37,40 % | 12.081.932 | -0,20 pp | The Reporting Persons acquired their Shares for investment and are filing this Schedule … |
| 12.02.2026 | Neal C. Bradsher | Aktivist (13D/A) | 37,40 % | 12.082.089 | -0,20 pp | The Reporting Persons acquired their Shares for investment and are filing this Schedule … |
| 09.05.2025 | AWM Investment Company, Inc. | Passiv (13G/A) | 10,00 % | 2.857.069 | +2,50 pp | |
| 04.03.2025 | BIO-RAD LABORATORIES, INC | Passiv (13G/A) | 9,70 % | 2.764.078 | Neu | |
| 14.02.2025 | AWM Investment Company, Inc. | Passiv (13G/A) | 7,50 % | 1.306.309 | Neu | |
| 10.02.2025 | NEAL C. BRADSHER | Aktivist (13D/A) | 40,20 % | 11.560.350 | Neu | The Reporting Persons acquired their Shares for investment and are filing this Schedule … |
| 10.02.2025 | BROADWOOD CAPITAL INC. | Aktivist (13D/A) | 40,20 % | 11.560.193 | Neu | The Reporting Persons acquired their Shares for investment and are filing this Schedule … |
| 10.02.2025 | BROADWOOD PARTNERS, L.P. | Aktivist (13D/A) | 40,20 % | 11.560.193 | Neu | The Reporting Persons acquired their Shares for investment and are filing this Schedule … |
| 27.12.2024 | Patrick W. Smith | Passiv (13G/A) | 10,50 % | 1.773.903 | Neu | |
| 27.12.2024 | PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 | Passiv (13G/A) | 10,50 % | 1.773.903 | Neu | |
| 15.04.2024 | Broadwood Capital, Inc. | Aktivist (13D/A) | 37,60 % | 5.079.159 | Neu | |
| 15.04.2024 | Neal C. Bradsher | Aktivist (13D/A) | 37,60 % | 5.079.316 | Neu | |
| 15.04.2024 | Broadwood Partners, L.P. | Aktivist (13D/A) | 37,60 % | 5.079.159 | Neu |
Stammdaten
OncoCyte Corporation, ein Molekulardiagnostik-Unternehmen, erforscht, entwickelt und vermarktet proprietäre laborentwickelte Tests zur Krebserkennung in den Vereinigten Staaten und international. Das Unternehmen bietet DetermaRx an, einen Molekular-Test für Adenokarzinom der Lunge im frühen Stadium; und DetermaIO, einen proprietären Gen-Expressions-Test. Es bietet zudem Biomarker-Entdeckungs-Tests, Test-Design und -Entwicklung sowie klinische Studiensupport-Services sowie verschiedene Biomarker-Tests für Pharmaunternehmen. Das Unternehmen hat eine Kooperationsvereinbarung mit Life Technologies Corporation zur Entwicklung und Zusammenarbeit bei der Vermarktung von Oncomine Comprehensive Assay Plus und Determa IO Test zur Verwendung mit Ion Torrent Genexus integriertem Sequenzer und Reinigungssystem. OncoCyte Corporation wurde 2009 gegründet und ist in Irvine, Kalifornien ansässig.
Unternehmen & Branche
| Name | Insight Molecular Diagnostics Inc. |
|---|---|
| Ticker | IMDX |
| CIK | 0001642380 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Medical - Diagnostics & Research |
| SIC | 2835 · In Vitro & In Vivo Diagnostic Substances |
Wertpapier & Kennzahlen
| CUSIP | 68235C206 |
|---|---|
| ISIN | US68235C2061 |
| Typ | Common Stock |
| Marktkapitalisierung | 155,7 Mio. USD |
| Beta | 1,65 |
Bewertung
| KUV (P/S) | 38,41 vs. 1.821,14 (2021) ▼ |
|---|---|
| FCF-Rendite | -16,3 % vs. -1,0 % (2021) ▼ |
Qualität & Bilanz
| Bruttomarge | 56,7 % vs. 64,6 % (2021) ▼ |
|---|---|
| Operative Marge | -1.260,8 % vs. -2.444,3 % (2021) ▲ |
| Nettomarge | -1.238,5 % vs. -2.916,2 % (2021) ▲ |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | 61,38 | 1,11 | 1,01 | – | – | |
| KUV (P/S) | 1.821,14 | 39,75 | 13,74 | 22,08 | 53,05 | |
| FCF-Rendite | -1,0 % | -131,0 % | -114,3 % | -51,0 % | -11,8 % | |
| Qualität & Bilanz | ||||||
| Bruttomarge | 64,6 % | -1,9 % | 27,5 % | 39,3 % | 56,7 % | |
| Operative Marge | -2.444,3 % | -1.878,6 % | -1.672,4 % | -3.245,1 % | -1.260,8 % | |
| Nettomarge | -2.916,2 % | -7.609,8 % | -1.848,4 % | -3.225,0 % | -1.238,5 % | |
| ROIC | -98,3 % | -212,6 % | -135,7 % | – | – | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 32.000 | -4.290.000 | -0,12 | 40.427.000 | -10.691.000 |
| 2025-12-31 | 10-K | 4.055.000 | -50.222.000 | -1,65 | 25.756.000 | -31.464.000 |
| 2025-09-30 | 10-Q | 260.000 | -10.854.000 | -0,34 | 43.937.000 | -9.196.000 |
| 2025-06-30 | 10-Q | 518.000 | -9.742.000 | -0,30 | 50.517.000 | 1.098.000 |
| 2025-03-31 | 10-Q | 2.138.000 | -6.671.000 | -0,26 | 60.360.000 | 10.218.000 |
| 2024-12-31 | 10-K | 1.881.000 | -60.663.000 | -4,66 | 35.081.000 | -12.274.000 |
| 2024-09-30 | 10-Q | 115.000 | -13.493.000 | -0,98 | 70.216.000 | 9.711.000 |
| 2024-06-30 | 10-Q | 104.000 | -4.530.000 | -0,36 | 74.720.000 | 22.703.000 |
| 2024-03-31 | 10-Q | 176.000 | -9.129.000 | -1,13 | 70.973.000 | 11.588.000 |
| 2023-12-31 | 10-K | 1.503.000 | -27.781.000 | -3,75 | 74.892.000 | 20.468.000 |
| 2023-09-30 | 10-Q | 429.000 | -6.489.000 | -0,81 | 81.587.000 | 36.143.000 |
| 2023-06-30 | 10-Q | 463.000 | -8.333.000 | -1,07 | 87.540.000 | 42.181.000 |
| 2023-03-31 | 10-Q | 297.000 | 3.033.000 | 0,40 | 82.800.000 | 36.514.000 |
| 2022-12-31 | 10-K | 958.000 | -72.902.000 | -13,25 | 100.091.000 | 34.292.000 |
| 2022-09-30 | 10-Q | 67.000 | -9.333.000 | -1,62 | 157.344.000 | 76.857.000 |
| 2022-06-30 | 10-Q | 237.000 | -8.300.000 | -1,48 | 171.051.000 | 83.243.000 |
| 2022-03-31 | 10-Q | 380.000 | -10.291.000 | -0,11 | 146.273.000 | 56.967.000 |
| 2021-12-31 | 10-K | 2.198.000 | -64.097.000 | 159.563.000 | 65.217.000 | |
| 2021-09-30 | 10-Q | 984.000 | -13.800.000 | 168.341.000 | 99.349.000 | |
| 2021-06-30 | 10-Q | 2.030.000 | -10.493.000 | 177.382.000 | 102.666.000 |
Umsatz nach Segmenten & Regionen ⓘ
Geschäftssegmente
| Segment | FY 2025 | FY 2024 | FY 2023 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|
| Laboratory Services | 4,0 Mio. | – | – | 99,4 % | Neu | |
| Kitted Products | 24.000 | – | – | 0,6 % | Neu | |
| Pharma Services | – | 1,9 Mio. | 1,5 Mio. | – | – | |
| Laboratory Developed Test Services | – | 22.000 | 36.000 | – | – |
Regionen
| Region | FY 2025 | FY 2024 | FY 2023 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|
| US | 4,0 Mio. | 1,7 Mio. | 923.000 | 99,4 % | +140,9% | |
| Europe | 24.000 | – | – | 0,6 % | Neu | |
| Asia Pacific | – | 145.000 | 160.000 | – | – | |
| GB | – | 45.000 | 409.000 | – | – | |
| DE | – | 18.000 | – | – | – | |
| ES | – | – | 11.000 | – | – |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 13.05.2026 | 32.000 USD | -0,12 |
| Q3 2025 | 30.09.2025 | 10.11.2025 | 260.000 USD | -0,34 |
| Q2 2025 | 30.06.2025 | 11.08.2025 | 518.000 USD | -0,30 |
| Q1 2025 | 31.03.2025 | 13.05.2026 | 2,1 Mio. USD | -0,26 |
| Q3 2024 | 30.09.2024 | 10.11.2025 | 115.000 USD | -0,98 |
| Q2 2024 | 30.06.2024 | 11.08.2025 | 104.000 USD | -0,36 |
| Q1 2024 | 31.03.2024 | 12.05.2025 | 176.000 USD | -1,13 |
| Q3 2023 | 30.09.2023 | 12.11.2024 | 429.000 USD | -0,81 |
| Q2 2023 | 30.06.2023 | 08.08.2024 | 463.000 USD | -1,07 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 13.05.2026 | 10-Q | – | – | SEC » |
| 26.03.2026 | 10-K | 31.12.2025 | 85 Tage | SEC » |
| 10.11.2025 | 10-Q | 30.09.2025 | 41 Tage | SEC » |
| 11.08.2025 | 10-Q | 30.06.2025 | 42 Tage | SEC » |
| 12.05.2025 | 10-Q | 31.03.2025 | 42 Tage | SEC » |
| 24.03.2025 | 10-K | 31.12.2024 | 83 Tage | SEC » |
| 12.11.2024 | 10-Q | 30.09.2024 | 43 Tage | SEC » |
| 08.08.2024 | 10-Q | 30.06.2024 | 39 Tage | SEC » |
| 15.05.2024 | 10-Q | 31.03.2024 | 45 Tage | SEC » |
| 16.04.2024 | 10-K | 31.12.2023 | 107 Tage | SEC » |
| 09.11.2023 | 10-Q | 30.09.2023 | 40 Tage | SEC » |
| 10.08.2023 | 10-Q | 30.06.2023 | 41 Tage | SEC » |
| 15.05.2023 | 10-Q | 31.03.2023 | 45 Tage | SEC » |
| 01.05.2023 | 10-K/A | 31.12.2022 | 121 Tage | SEC » |
| 12.04.2023 | 10-K | 31.12.2022 | 102 Tage | SEC » |
| 10.11.2022 | 10-Q | 30.09.2022 | 41 Tage | SEC » |
| 12.08.2022 | 10-Q | 30.06.2022 | 43 Tage | SEC » |
| 12.05.2022 | 10-Q | 31.03.2022 | 42 Tage | SEC » |
| 02.05.2022 | 10-K/A | 31.12.2021 | 122 Tage | SEC » |
| 11.03.2022 | 10-K | 31.12.2021 | 70 Tage | SEC » |
| 09.11.2021 | 10-Q | 30.09.2021 | 40 Tage | SEC » |
| 11.08.2021 | 10-Q | 30.06.2021 | 42 Tage | SEC » |
| 17.05.2021 | 10-Q | 31.03.2021 | 47 Tage | SEC » |
| 30.04.2021 | 10-K/A | 31.12.2020 | 120 Tage | SEC » |
| 19.03.2021 | 10-K | 31.12.2020 | 78 Tage | SEC » |
| 12.11.2020 | 10-Q | 30.09.2020 | 43 Tage | SEC » |
| 29.07.2020 | 10-Q | 30.06.2020 | 29 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 02.10.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 19.09.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 10.03.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 15.10.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 17.06.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 31.05.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 23.05.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 10.08.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 14.07.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 09.06.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 11.05.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 02.03.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 21.12.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 05.12.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 23.11.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 26.09.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 10.08.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 03.08.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 01.08.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 30.06.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-14 | 10.700 | 5,10 | 54.570 |
| 2026-05-12 | 373 | 4,91 | 1.831 |
| 2026-05-06 | 1 | 4,58 | 5 |
| 2026-05-05 | 5 | 5,23 | 26 |
| 2026-04-30 | 37.952 | 3,83 | 145.356 |
| 2026-04-28 | 2.908 | 3,84 | 11.167 |
| 2026-04-24 | 5.912 | 3,52 | 20.810 |
| 2026-04-21 | 3.788 | 3,99 | 15.114 |
| 2026-04-17 | 777 | 3,51 | 2.727 |
| 2026-04-16 | 237 | 3,42 | 811 |
| 2026-04-08 | 2.564 | 3,21 | 8.230 |
| 2026-04-07 | 1.362 | 3,37 | 4.590 |
| 2026-04-02 | 23.732 | 3,44 | 81.638 |
| 2026-04-01 | 71.913 | 3,28 | 235.875 |
| 2026-03-04 | 501 | 5,45 | 2.730 |
| 2026-03-03 | 85.000 | 4,94 | 419.900 |
Hinweis
Ersteller: Verantwortlich für Erstellung und Verbreitung ist der Betreiber dieser Website (siehe Impressum). Die Einstufung wird arbeitstäglich automatisiert neu berechnet — Stand: 14.06.2026.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in besprochenen Werten halten. Methodik: Signal-Komponenten und Gewichte.